# Enara Bio: Biotechnology, Oxford, United Kingdom

> Enara Bio: Enara Bio Limited, based in Oxford, United Kingdom, is a biotechnology company focused on developing innovative cancer immunotherapies.

Source: https://millionrounds.com/startup/enara-bio (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# Enara Bio

Enara Bio Limited, based in Oxford, United Kingdom, is a biotechnology company focused on developing innovative cancer immunotherapies.

Funding reported Last round: Series A

Biotechnology Oxford, United Kingdom

Company summary

- **Founded:** 2016 10 years old
- **Team:** 67 51 to 200 people
- **Funding reported:** 32.5M as listed, currency not stated
- **Last round:** Series A Nov 2019

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Enara Bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Enara Bio

Enara Bio Limited, based in Oxford, United Kingdom, is a biotechnology company focused on developing innovative cancer immunotherapies.

Founded in November 2016, Enara Bio specializes in targeting unique cancer antigens known as Dark Antigens®, which are derived from non-coding regions of the genome. The company operates with a dedicated team of approximately 61 employees and has secured significant funding to advance its research and development efforts. Enara Bio utilizes two proprietary technology platforms: the EDAPT® platform for discovering Dark Antigens and the EnTiCE® platform for optimizing bispecific T-cell engagers. These platforms enable the development of targeted immunotherapies aimed at improving treatment outcomes for patients with solid tumors. The company's lead candidate, ENA101, is a bispecific T-cell engager that is progressing toward first-in-human clinical studies planned for early 2026. Enara Bio collaborates with leading pharmaceutical companies and research institutions to further its mission of transforming cancer treatment through the exploration of Dark Antigens.

## What company datasets say Enara Bio raised

Funding, as reported

Reported in all **32.5M** in the source's currency

Rounds **2**

Last round **Series A**

Last round size **32.5M**

Last round date **Nov 2019**

Investors listed **5**

## Founders and team

From Enara Bio's own website: 1 founder, 10 on the team.

**Houman Ashrafian** Co-founder of Enara Bio

- **Kevin Pojasek** President and CEO
- **Stacey Davis** CBO and CFO
- **Bauke Anninga** Director
- **Clive Wood** Director
- **Joseph Dukes** Board of Directors
- **Josh Resnick** Director
- **Kate Bingham** Director
- **Mike Dybbs** Director
- **Rana Al-Hallaq** Director
- **Robert Ang** Chair

## The company, in detail

What they build

Known for

health care immunology medical research tumor-infiltrating lymphocytes bispecific t-cell engagers oncology research education information technology & services mass spectrometry cancer vaccine development biotech collaborations epigenetic alterations hospital & health care cancer immunotherapy immunopeptidomics medical

Built with from their website

Google Tag Manager Atlassian PWA Font Awesome YouTube Viewport Meta Digital Ocean Spaces Element UI Mimecast smtp2go

+8 more

Varnish Act! KnowBe4 Mist Priority Hints BASE Allbound PRM Teamtailor

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, 325414, SIC 2834
- **Region:** England
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/enara-bio)

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**RQ Biotechnology Ltd.** London · founded 2022](https://millionrounds.com/startup/rq-biotechnology-ltd)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Oxular** Oxford · founded 2014](https://millionrounds.com/startup/oxular)
- [**Maxion Therapeutics** Cambridge · founded 2020](https://millionrounds.com/startup/maxion-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Enara Bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)